Active Epstein-barr Virus Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-08-19
Clinical Trial Update: Sintilimab and Lenalidomide as a Treatment for CAEBV [Phase 2]
Phase 2 clinical trial evaluating sintilimab plus lenalidomide for chronic active Epstein-Barr virus disease (CAEBV).